|Articles|January 2, 2014

Pharmaceutical Technology

  • Pharmaceutical Technology-01-02-2014
  • Volume 38
  • Issue 1

Pharmaceutical Technology, January 2014 Issue (PDF)

Click the title above to open the Pharmaceutical Technology January 2014 issue in an interactive PDF format.

Articles in this issue

over 12 years ago

UK Biotech Gains Momentum

almost 13 years ago

Drugs, At What Cost?

almost 13 years ago

Innovation and Market Growth in Brazil

almost 13 years ago

R&D in Transition

almost 13 years ago

Battling Off-Weight Tablets

almost 13 years ago

Metrics Sought to Ensure Drug Quality

Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.